Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a -22.526% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a CCOC(=O)c1cc2cc(OC)ccc2nc1C
b Cc1ccc(NC(=S)c2ccncc2)c(C)c1
c CC(Oc1cccc(Cl)c1)C(=O)Nc1ccc(S(=O)(=O)NC2=NCCCCC2)cc1
Answer: c. CC(Oc1cccc(Cl)c1)C(=O)Nc1ccc(S(=O)(=O)NC2=NCCCCC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(Oc1cccc(Cl)c1)C(=O)Nc1ccc(S(=O)(=O)NC2=NCCCCC2)cc1
CC(Oc1cccc(Cl)c1)C(=O)Nc1ccc(S(=O)(=O)NC2=NCCCCC2)cc1
2-(3-chlorophenoxy)-N-[4-(3,4,5,6-tetrahydro-2H-azepin-7-ylsulfamoyl)phenyl]propanamide